James Posada News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from James Posada. Real-time updates on events, politics, business and more.

Novel Lupus Approach Yields Mixed Results in Early Trial

February 8, 2024

Hints of benefit seen in patients with more active disease

United States James Posada John Gever British Isles Lupus Assessment Group Resolve Therapeutics Cutaneous Lupus Erythematosus Disease Area

Source: medpagetoday.com

Resolve Therapeutics Completes Enrollment of Phase 2 Long Covid Clinical Trial

November 9, 2022

/PRNewswire/ -- Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced that its phase 2...

Sankt Peterburg James Posada Resolve Therapeutics Health Care Amp Hospitals Medical Pharmaceuticals Pharmaceuticals

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

James Posada News Today

Novel Lupus Approach Yields Mixed Results in Early Trial

Resolve Therapeutics Completes Enrollment of Phase 2 Long Covid Clinical Trial

Explore More Categories